Approval Year
| Substance Class |
Protein
Created
by
admin
on
Edited
Tue Apr 01 18:22:09 GMT 2025
by
admin
on
Tue Apr 01 18:22:09 GMT 2025
|
| Protein Sub Type | |
| Sequence Type | COMPLETE |
| Record UNII |
OUJ3871L27
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Common Name | English | ||
|
Preferred Name | English | ||
|
Common Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
OUJ3871L27
Created by
admin on Tue Apr 01 18:22:09 GMT 2025 , Edited by admin on Tue Apr 01 18:22:09 GMT 2025
|
PRIMARY |
| From | To |
|---|---|
| 1_113 | 1_196 |
| Glycosylation Type | HUMAN |
| Glycosylation Link Type | Site |
|---|---|
| N | 1_20 |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
RADIOLIGAND->TARGET |
Expression in prostate cancer is higher in carcinomas of lower Gleason score. GRP-R imaging appears complimentary to that of imaging prostate-specific membrane antigen.
Kd
|
||
|
RADIOLIGAND->TARGET |
|
||
|
RADIOLIGAND->TARGET |
|
||
|
INHIBITOR -> TARGET |
Pre-clinical
|
||
|
LIGAND->TARGET |
|
||
|
INHIBITOR -> TARGET |
|
| Name | Property Type | Amount | Referenced Substance | Defining | Parameters | References |
|---|---|---|---|---|---|---|
| MOL_WEIGHT | CHEMICAL |
|